Surgery Partners Files 8-K on Shareholder Vote Matters

TL;DR

SGRY filed an 8-K for shareholder vote matters on June 6th.

AI Summary

Surgery Partners, Inc. filed an 8-K on June 11, 2024, reporting on matters submitted to a vote of security holders on June 6, 2024. The filing details the company's principal executive offices located at 340 Seven Springs Way, Suite 600, Brentwood, Tennessee, 37027.

Why It Matters

This filing informs investors about significant corporate actions that were put to a vote by shareholders, impacting corporate governance and strategic decisions.

Risk Assessment

Risk Level: low — This is a routine filing reporting on a shareholder vote, not indicating any immediate financial distress or significant operational change.

Key Players & Entities

• Surgery Partners, Inc. (company) — Registrant
• June 6, 2024 (date) — Date of earliest event reported
• June 11, 2024 (date) — Date of Report
• Brentwood, Tennessee (location) — Principal Executive Offices Location

FAQ

Key Financial Figures

• $0.01 — ich registered Common Stock, par value $0.01 per share SGRY The Nasdaq Global Select

Filing Documents

• sgry-20240606.htm (8-K) — 38KB
• 0001638833-24-000127.txt ( ) — 159KB
• sgry-20240606.xsd (EX-101.SCH) — 2KB
• sgry-20240606_lab.xml (EX-101.LAB) — 21KB
• sgry-20240606_pre.xml (EX-101.PRE) — 12KB
• sgry-20240606_htm.xml (XML) — 3KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders On June 6, 2024, Surgery Partners, Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting"). As of the close of business on April 8, 2024, the record date for the Annual Meeting (the "Record Date"), 127,101,670 shares of the Company's common stock were outstanding and entitled to vote. The matters voted on at the Annual Meeting and the final results of such voting were as follows: Proposal 1: Election of Class III directors. The stockholders elected each of the director nominees to serve as a Class III director until the Company's 2027 annual meeting of stockholders and until each such successor has been elected and qualified. Each of the nominees was a current Class III director of the Company who was re-elected. The results of the vote were as follows: Name Votes For Votes Withheld Broker Non-Votes Clifford G. Adlerz 115,827,639 6,509,409 1,952,220 J. Eric Evans 115,825,708 6,511,340 1,952,220 Blair E. Hendrix 100,770,568 21,566,480 1,952,220 Andrew T. Kaplan 115,622,481 6,714,567 1,952,220 Proposal 2: Advisory vote on executive compensation. The stockholders approved on a non-binding, advisory basis the compensation paid by the Company to its named executive officers, as disclosed in the Company's Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 25, 2024. The results of the vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes 121,165,656 1,057,012 114,380 1,952,220 Proposal 3: Approval of employee stock purchase plan. The stockholders approved the employee stock purchase plan. The results of the vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes 122,222,115 23,346 91,587 1,952,220 The employee stock purchase plan was adopted by the Board to be effective within 12 months following approval by the Company's stockholders. The employee stock purchase plan

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SURGERY PARTNERS, INC. By: /s/ Jennifer B. Baldock Jennifer B. Baldock Executive Vice President, Chief Administrative and Development Officer Date: June 11, 2024

View Full Filing

View this 8-K filing on SEC EDGAR